+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Cancer Supportive Care - Global Strategic Business Report - Product Thumbnail Image

Cancer Supportive Care - Global Strategic Business Report

  • Report
  • November 2026
  • 262 Pages
  • Global
From
Allergy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Allergy Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Cervical Intraepithelial Neoplasia- Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HIV-related Lymphoma Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

HIV-related Lymphoma Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Bronchitis Treatments: Global Markets - Product Thumbnail Image

Bronchitis Treatments: Global Markets

  • Report
  • November 2022
  • 98 Pages
  • Global
From
From
Sleeping Aids Market Report 2026 - Product Thumbnail Image

Sleeping Aids Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Asthma Drugs Market Report 2026 - Product Thumbnail Image

Asthma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Prostate Health Market - Global Forecast 2026-2032 - Product Thumbnail Image

Prostate Health Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
Glucocorticoid Induced Tumor Necrosis Factor - Pipeline Insight, 2025 - Product Thumbnail Image

Glucocorticoid Induced Tumor Necrosis Factor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator